Cancer Diagnostics – News and Features
News
Acrongenomics Retains KGMC Group
KGMC Group will work with Acrongenomics to complete formal validations of the advanced Nano-JETA™ platform.
News
Affymetrix and PathWork Forge Collaboration to Develop New Cancer Diagnostics
PathWork to use Affymetrix microarray technology for the development of tests for cancer.
News
Gen-Probe to Collaborate with Molecular Profiling Institute to Bolster Oncology Strategy
Collaboration to accelerate market development for Gen-Probe's pipeline of novel cancer diagnostics.
News
Rubicon Genomics and Abbott Molecular Sign Agreement to Co-Develop Simple Non-Invasive Cancer Diagnostic Tests
MethylPlex™ is designed to be a very sensitive and simple method to detect the patterns of abnormal DNA methylation
News
Researchers Use New Method to Discover Gene Rearrangements
Genes rearrangements in prostate cancer cells may play a role in the development and progression of the disease.
News
Affymetrix and COG to Discover and Validate Gene Expression Signatures For Childhood
GeneChip Used to Identify Genetic Information Associated with Leukemia, Brain Tumors and Other Solid Tumors.
News
bioMérieux and ExonHit Extend Their Strategic Collaboration
The objective of the extended collaboration is to develop DNA microarrays to detect genetic cancer markers.
News
Ciphergen, UCL, and UCL BioMedica Sign Collaboration Agreement
Ciphergen and its collaborators will work together to further validate and characterize ovarian cancer biomarkers.
News
NCI Awards to Establish Seven Centers of Cancer Nanotechnology Excellence
First year awards totaling $26.3 million will help establish seven Centers of Cancer Nanotechnology Excellence.
News
Discovery of Blood Serum Biomarkers for Breast Cancer
Power3 Medical Products, Inc. has discovered a group of breast cancer protein biomarkers in preliminary studies of blood serum.
Advertisement
